nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Laryngeal oedema—Niacin—atherosclerosis	0.0161	0.0259	CcSEcCtD
Propericiazine—Glaucoma—Niacin—atherosclerosis	0.0138	0.0221	CcSEcCtD
Propericiazine—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0137	0.022	CcSEcCtD
Propericiazine—Jaundice cholestatic—Simvastatin—atherosclerosis	0.0128	0.0206	CcSEcCtD
Propericiazine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.0127	0.0205	CcSEcCtD
Propericiazine—Jaundice cholestatic—Niacin—atherosclerosis	0.0118	0.0189	CcSEcCtD
Propericiazine—Jaundice cholestatic—Pravastatin—atherosclerosis	0.0116	0.0186	CcSEcCtD
Propericiazine—Gynaecomastia—Lovastatin—atherosclerosis	0.0108	0.0173	CcSEcCtD
Propericiazine—Gynaecomastia—Simvastatin—atherosclerosis	0.0101	0.0162	CcSEcCtD
Propericiazine—Photosensitivity—Lovastatin—atherosclerosis	0.00997	0.016	CcSEcCtD
Propericiazine—Photosensitivity—Ezetimibe—atherosclerosis	0.00978	0.0157	CcSEcCtD
Propericiazine—Photosensitivity—Simvastatin—atherosclerosis	0.00932	0.015	CcSEcCtD
Propericiazine—Gynaecomastia—Pravastatin—atherosclerosis	0.00912	0.0147	CcSEcCtD
Propericiazine—Photosensitivity—Pravastatin—atherosclerosis	0.00843	0.0135	CcSEcCtD
Propericiazine—Jaundice—Rosuvastatin—atherosclerosis	0.00776	0.0125	CcSEcCtD
Propericiazine—Eosinophilia—Lovastatin—atherosclerosis	0.00749	0.012	CcSEcCtD
Propericiazine—Eosinophilia—Ezetimibe—atherosclerosis	0.00735	0.0118	CcSEcCtD
Propericiazine—Eosinophilia—Simvastatin—atherosclerosis	0.00701	0.0113	CcSEcCtD
Propericiazine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00697	0.0112	CcSEcCtD
Propericiazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.0069	0.0111	CcSEcCtD
Propericiazine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00683	0.011	CcSEcCtD
Propericiazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00677	0.0109	CcSEcCtD
Propericiazine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00652	0.0105	CcSEcCtD
Propericiazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00646	0.0104	CcSEcCtD
Propericiazine—Jaundice—Ezetimibe—atherosclerosis	0.00645	0.0104	CcSEcCtD
Propericiazine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00638	0.0103	CcSEcCtD
Propericiazine—Eosinophilia—Pravastatin—atherosclerosis	0.00633	0.0102	CcSEcCtD
Propericiazine—Sweating increased—Pravastatin—atherosclerosis	0.00623	0.01	CcSEcCtD
Propericiazine—Jaundice—Simvastatin—atherosclerosis	0.00615	0.00988	CcSEcCtD
Propericiazine—Aceprometazine—HRH1—atherosclerosis	0.00601	0.12	CrCbGaD
Propericiazine—Erectile dysfunction—Niacin—atherosclerosis	0.00598	0.00961	CcSEcCtD
Propericiazine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00589	0.00946	CcSEcCtD
Propericiazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00584	0.00938	CcSEcCtD
Propericiazine—Weight increased—Pravastatin—atherosclerosis	0.00582	0.00935	CcSEcCtD
Propericiazine—Angioedema—Rosuvastatin—atherosclerosis	0.00568	0.00913	CcSEcCtD
Propericiazine—Jaundice—Niacin—atherosclerosis	0.00565	0.00907	CcSEcCtD
Propericiazine—Methdilazine—HRH1—atherosclerosis	0.00556	0.111	CrCbGaD
Propericiazine—Jaundice—Pravastatin—atherosclerosis	0.00556	0.00893	CcSEcCtD
Propericiazine—Confusional state—Rosuvastatin—atherosclerosis	0.00512	0.00822	CcSEcCtD
Propericiazine—Infection—Rosuvastatin—atherosclerosis	0.00504	0.0081	CcSEcCtD
Propericiazine—Vision blurred—Lovastatin—atherosclerosis	0.00497	0.00798	CcSEcCtD
Propericiazine—Tremor—Lovastatin—atherosclerosis	0.00494	0.00793	CcSEcCtD
Propericiazine—Angioedema—Lovastatin—atherosclerosis	0.00482	0.00774	CcSEcCtD
Propericiazine—Cardiac disorder—Pravastatin—atherosclerosis	0.00475	0.00763	CcSEcCtD
Propericiazine—Angioedema—Ezetimibe—atherosclerosis	0.00472	0.00759	CcSEcCtD
Propericiazine—Vision blurred—Simvastatin—atherosclerosis	0.00465	0.00746	CcSEcCtD
Propericiazine—Arrhythmia—Niacin—atherosclerosis	0.00465	0.00746	CcSEcCtD
Propericiazine—Tremor—Simvastatin—atherosclerosis	0.00462	0.00742	CcSEcCtD
Propericiazine—Insomnia—Rosuvastatin—atherosclerosis	0.00459	0.00738	CcSEcCtD
Propericiazine—Arrhythmia—Pravastatin—atherosclerosis	0.00457	0.00735	CcSEcCtD
Propericiazine—Angioedema—Simvastatin—atherosclerosis	0.0045	0.00724	CcSEcCtD
Propericiazine—Dry mouth—Lovastatin—atherosclerosis	0.00439	0.00705	CcSEcCtD
Propericiazine—Constipation—Rosuvastatin—atherosclerosis	0.00434	0.00697	CcSEcCtD
Propericiazine—Confusional state—Lovastatin—atherosclerosis	0.00434	0.00697	CcSEcCtD
Propericiazine—Dry mouth—Ezetimibe—atherosclerosis	0.0043	0.00692	CcSEcCtD
Propericiazine—Infection—Lovastatin—atherosclerosis	0.00427	0.00687	CcSEcCtD
Propericiazine—Vision blurred—Niacin—atherosclerosis	0.00427	0.00685	CcSEcCtD
Propericiazine—Confusional state—Ezetimibe—atherosclerosis	0.00425	0.00683	CcSEcCtD
Propericiazine—Vision blurred—Pravastatin—atherosclerosis	0.0042	0.00675	CcSEcCtD
Propericiazine—Infection—Ezetimibe—atherosclerosis	0.00419	0.00673	CcSEcCtD
Propericiazine—Tremor—Pravastatin—atherosclerosis	0.00418	0.00671	CcSEcCtD
Propericiazine—Angioedema—Niacin—atherosclerosis	0.00414	0.00665	CcSEcCtD
Propericiazine—Angioedema—Pravastatin—atherosclerosis	0.00407	0.00654	CcSEcCtD
Propericiazine—Confusional state—Simvastatin—atherosclerosis	0.00406	0.00652	CcSEcCtD
Propericiazine—Alimemazine—HRH1—atherosclerosis	0.00406	0.0813	CrCbGaD
Propericiazine—Oedema—Simvastatin—atherosclerosis	0.00402	0.00646	CcSEcCtD
Propericiazine—Infection—Simvastatin—atherosclerosis	0.004	0.00642	CcSEcCtD
Propericiazine—Insomnia—Lovastatin—atherosclerosis	0.00389	0.00625	CcSEcCtD
Propericiazine—Dyspnoea—Lovastatin—atherosclerosis	0.00383	0.00616	CcSEcCtD
Propericiazine—Insomnia—Ezetimibe—atherosclerosis	0.00382	0.00613	CcSEcCtD
Propericiazine—Dry mouth—Niacin—atherosclerosis	0.00377	0.00606	CcSEcCtD
Propericiazine—Dyspnoea—Ezetimibe—atherosclerosis	0.00376	0.00604	CcSEcCtD
Propericiazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00374	0.00601	CcSEcCtD
Propericiazine—Oedema—Niacin—atherosclerosis	0.00369	0.00594	CcSEcCtD
Propericiazine—Constipation—Lovastatin—atherosclerosis	0.00368	0.00591	CcSEcCtD
Propericiazine—Confusional state—Pravastatin—atherosclerosis	0.00367	0.00589	CcSEcCtD
Propericiazine—Insomnia—Simvastatin—atherosclerosis	0.00364	0.00585	CcSEcCtD
Propericiazine—Oedema—Pravastatin—atherosclerosis	0.00364	0.00584	CcSEcCtD
Propericiazine—Infection—Pravastatin—atherosclerosis	0.00361	0.00581	CcSEcCtD
Propericiazine—Constipation—Ezetimibe—atherosclerosis	0.00361	0.0058	CcSEcCtD
Propericiazine—Tachycardia—Niacin—atherosclerosis	0.00361	0.00579	CcSEcCtD
Propericiazine—Dyspnoea—Simvastatin—atherosclerosis	0.00359	0.00576	CcSEcCtD
Propericiazine—Hyperhidrosis—Niacin—atherosclerosis	0.00357	0.00574	CcSEcCtD
Propericiazine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00352	0.00565	CcSEcCtD
Propericiazine—Mequitazine—HRH1—atherosclerosis	0.00349	0.07	CrCbGaD
Propericiazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00347	0.00558	CcSEcCtD
Propericiazine—Hypotension—Niacin—atherosclerosis	0.00345	0.00555	CcSEcCtD
Propericiazine—Constipation—Simvastatin—atherosclerosis	0.00344	0.00553	CcSEcCtD
Propericiazine—Body temperature increased—Lovastatin—atherosclerosis	0.0034	0.00546	CcSEcCtD
Propericiazine—Insomnia—Niacin—atherosclerosis	0.00334	0.00537	CcSEcCtD
Propericiazine—Body temperature increased—Ezetimibe—atherosclerosis	0.00334	0.00536	CcSEcCtD
Propericiazine—Dyspnoea—Niacin—atherosclerosis	0.00329	0.00529	CcSEcCtD
Propericiazine—Insomnia—Pravastatin—atherosclerosis	0.00329	0.00529	CcSEcCtD
Propericiazine—Somnolence—Niacin—atherosclerosis	0.00328	0.00528	CcSEcCtD
Propericiazine—Dyspnoea—Pravastatin—atherosclerosis	0.00324	0.00521	CcSEcCtD
Propericiazine—Rash—Rosuvastatin—atherosclerosis	0.0032	0.00514	CcSEcCtD
Propericiazine—Dermatitis—Rosuvastatin—atherosclerosis	0.0032	0.00514	CcSEcCtD
Propericiazine—Body temperature increased—Simvastatin—atherosclerosis	0.00318	0.00511	CcSEcCtD
Propericiazine—Hypersensitivity—Lovastatin—atherosclerosis	0.00317	0.00509	CcSEcCtD
Propericiazine—Constipation—Pravastatin—atherosclerosis	0.00311	0.005	CcSEcCtD
Propericiazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00311	0.00499	CcSEcCtD
Propericiazine—Nausea—Rosuvastatin—atherosclerosis	0.00301	0.00484	CcSEcCtD
Propericiazine—Hypersensitivity—Simvastatin—atherosclerosis	0.00296	0.00476	CcSEcCtD
Propericiazine—Diarrhoea—Lovastatin—atherosclerosis	0.00294	0.00473	CcSEcCtD
Propericiazine—Body temperature increased—Niacin—atherosclerosis	0.00292	0.00469	CcSEcCtD
Propericiazine—Diarrhoea—Ezetimibe—atherosclerosis	0.00289	0.00464	CcSEcCtD
Propericiazine—Zuclopenthixol—HRH1—atherosclerosis	0.00288	0.0577	CrCbGaD
Propericiazine—Body temperature increased—Pravastatin—atherosclerosis	0.00288	0.00462	CcSEcCtD
Propericiazine—Diarrhoea—Simvastatin—atherosclerosis	0.00275	0.00442	CcSEcCtD
Propericiazine—Vomiting—Lovastatin—atherosclerosis	0.00273	0.00439	CcSEcCtD
Propericiazine—Hypersensitivity—Niacin—atherosclerosis	0.00272	0.00437	CcSEcCtD
Propericiazine—Rash—Lovastatin—atherosclerosis	0.00271	0.00436	CcSEcCtD
Propericiazine—Dermatitis—Lovastatin—atherosclerosis	0.00271	0.00435	CcSEcCtD
Propericiazine—Vomiting—Ezetimibe—atherosclerosis	0.00268	0.00431	CcSEcCtD
Propericiazine—Hypersensitivity—Pravastatin—atherosclerosis	0.00268	0.00431	CcSEcCtD
Propericiazine—Rash—Ezetimibe—atherosclerosis	0.00266	0.00427	CcSEcCtD
Propericiazine—Dermatitis—Ezetimibe—atherosclerosis	0.00266	0.00427	CcSEcCtD
Propericiazine—Vomiting—Simvastatin—atherosclerosis	0.00256	0.00411	CcSEcCtD
Propericiazine—Nausea—Lovastatin—atherosclerosis	0.00256	0.0041	CcSEcCtD
Propericiazine—Rash—Simvastatin—atherosclerosis	0.00254	0.00408	CcSEcCtD
Propericiazine—Dermatitis—Simvastatin—atherosclerosis	0.00253	0.00407	CcSEcCtD
Propericiazine—Diarrhoea—Niacin—atherosclerosis	0.00253	0.00406	CcSEcCtD
Propericiazine—Nausea—Ezetimibe—atherosclerosis	0.00251	0.00403	CcSEcCtD
Propericiazine—Diarrhoea—Pravastatin—atherosclerosis	0.00249	0.004	CcSEcCtD
Propericiazine—Thiothixene—HRH1—atherosclerosis	0.00248	0.0498	CrCbGaD
Propericiazine—Mesoridazine—HRH1—atherosclerosis	0.00245	0.0491	CrCbGaD
Propericiazine—Nausea—Simvastatin—atherosclerosis	0.00239	0.00384	CcSEcCtD
Propericiazine—Prochlorperazine—HRH1—atherosclerosis	0.00237	0.0476	CrCbGaD
Propericiazine—Vomiting—Niacin—atherosclerosis	0.00235	0.00377	CcSEcCtD
Propericiazine—Rash—Niacin—atherosclerosis	0.00233	0.00374	CcSEcCtD
Propericiazine—Dermatitis—Niacin—atherosclerosis	0.00233	0.00374	CcSEcCtD
Propericiazine—Vomiting—Pravastatin—atherosclerosis	0.00231	0.00372	CcSEcCtD
Propericiazine—Rash—Pravastatin—atherosclerosis	0.00229	0.00368	CcSEcCtD
Propericiazine—Dermatitis—Pravastatin—atherosclerosis	0.00229	0.00368	CcSEcCtD
Propericiazine—Nausea—Niacin—atherosclerosis	0.00219	0.00353	CcSEcCtD
Propericiazine—Nausea—Pravastatin—atherosclerosis	0.00216	0.00347	CcSEcCtD
Propericiazine—Fluphenazine—HRH1—atherosclerosis	0.00215	0.043	CrCbGaD
Propericiazine—Propiomazine—HRH1—atherosclerosis	0.00207	0.0414	CrCbGaD
Propericiazine—Thioridazine—HRH1—atherosclerosis	0.00185	0.0371	CrCbGaD
Propericiazine—Methotrimeprazine—HRH1—atherosclerosis	0.00177	0.0354	CrCbGaD
Propericiazine—Promethazine—HRH1—atherosclerosis	0.00174	0.0349	CrCbGaD
Propericiazine—Trifluoperazine—HRH1—atherosclerosis	0.00172	0.0344	CrCbGaD
Propericiazine—Perphenazine—HRH1—atherosclerosis	0.0017	0.034	CrCbGaD
Propericiazine—Quetiapine—HRH1—atherosclerosis	0.00166	0.0334	CrCbGaD
Propericiazine—Promazine—HRH1—atherosclerosis	0.00153	0.0307	CrCbGaD
Propericiazine—Chlorpromazine—HRH1—atherosclerosis	0.00135	0.027	CrCbGaD
Propericiazine—Acepromazine—ALB—atherosclerosis	0.000596	0.012	CrCbGaD
Propericiazine—Thioproperazine—ALB—atherosclerosis	0.000583	0.0117	CrCbGaD
Propericiazine—Thiothixene—ALB—atherosclerosis	0.000574	0.0115	CrCbGaD
Propericiazine—Pipotiazine—ALB—atherosclerosis	0.000574	0.0115	CrCbGaD
Propericiazine—Clomipramine—ALB—atherosclerosis	0.000453	0.00909	CrCbGaD
Propericiazine—Chlorpromazine—ALB—atherosclerosis	0.000311	0.00623	CrCbGaD
Propericiazine—DRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000216	0.000658	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GHRL—atherosclerosis	0.000216	0.000658	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CX3CL1—atherosclerosis	0.000215	0.000655	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL3—atherosclerosis	0.000214	0.000653	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—F2—atherosclerosis	0.000213	0.00065	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—EDN1—atherosclerosis	0.000213	0.000649	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CCL2—atherosclerosis	0.000212	0.000648	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL4—atherosclerosis	0.000212	0.000646	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CCL5—atherosclerosis	0.000211	0.000644	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS2—atherosclerosis	0.000211	0.000643	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—KNG1—atherosclerosis	0.000208	0.000636	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PLA2G1B—atherosclerosis	0.000208	0.000635	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000207	0.000632	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NCF1—atherosclerosis	0.000205	0.000625	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CG—atherosclerosis	0.000204	0.000622	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CNR2—atherosclerosis	0.000204	0.000621	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCL8—atherosclerosis	0.000203	0.000621	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MMP3—atherosclerosis	0.000203	0.00062	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000203	0.000619	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALOX5—atherosclerosis	0.000201	0.000613	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	0.000201	0.000613	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—F2—atherosclerosis	0.000199	0.000608	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOA2—atherosclerosis	0.000198	0.000603	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AGT—atherosclerosis	0.000196	0.000598	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCR2—atherosclerosis	0.000193	0.00059	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000193	0.00059	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	0.000193	0.00059	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CYBA—atherosclerosis	0.000192	0.000588	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	0.000192	0.000585	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000191	0.000582	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KNG1—atherosclerosis	0.000189	0.000578	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—UTS2—atherosclerosis	0.000189	0.000575	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PLAT—atherosclerosis	0.000188	0.000575	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PARP1—atherosclerosis	0.000188	0.000575	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GHRL—atherosclerosis	0.000188	0.000575	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGTR1—atherosclerosis	0.000188	0.000574	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IGF1—atherosclerosis	0.000187	0.00057	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	0.000182	0.000556	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VWF—atherosclerosis	0.000181	0.000554	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—F2—atherosclerosis	0.000181	0.000552	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CX3CR1—atherosclerosis	0.000181	0.000552	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASR—atherosclerosis	0.000181	0.000552	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	0.00018	0.00055	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NAMPT—atherosclerosis	0.00018	0.00055	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	0.000179	0.000547	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LIPC—atherosclerosis	0.000179	0.000547	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOC3—atherosclerosis	0.000178	0.000543	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SERPINE1—atherosclerosis	0.000177	0.000541	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000177	0.000541	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ALB—atherosclerosis	0.000177	0.00054	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LDLR—atherosclerosis	0.000177	0.00054	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	0.000177	0.000539	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—EDN1—atherosclerosis	0.000176	0.000536	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	0.000175	0.000534	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000174	0.000532	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000173	0.000529	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CETP—atherosclerosis	0.000173	0.000527	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS3—atherosclerosis	0.000169	0.000517	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CNR2—atherosclerosis	0.000168	0.000513	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCL8—atherosclerosis	0.000168	0.000513	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	0.000168	0.000512	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MMP3—atherosclerosis	0.000168	0.000512	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000166	0.000506	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SCARB1—atherosclerosis	0.000165	0.000505	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KNG1—atherosclerosis	0.000165	0.000505	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000164	0.000502	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	0.000163	0.000498	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCL2—atherosclerosis	0.000161	0.000492	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	0.00016	0.000489	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PLG—atherosclerosis	0.00016	0.000489	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EDN1—atherosclerosis	0.000159	0.000487	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	0.000158	0.000483	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	0.000158	0.000483	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL5—atherosclerosis	0.000158	0.000483	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	0.000158	0.000481	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMGCR—atherosclerosis	0.000156	0.000477	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000156	0.000477	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	0.000154	0.000471	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	0.000154	0.000471	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	0.000154	0.000471	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000152	0.000463	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000151	0.000461	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	0.00015	0.000459	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	0.00015	0.000457	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	0.000149	0.000454	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—F2—atherosclerosis	0.000148	0.000452	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	0.000148	0.000452	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP3—atherosclerosis	0.000147	0.000447	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF2—atherosclerosis	0.000146	0.000445	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000146	0.000445	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	0.000144	0.000441	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000142	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOB—atherosclerosis	0.000142	0.000432	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.00014	0.000429	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDN1—atherosclerosis	0.000139	0.000425	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCA1—atherosclerosis	0.000139	0.000425	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	0.000138	0.000422	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL5—atherosclerosis	0.000138	0.000422	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	0.000135	0.000413	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LPL—atherosclerosis	0.000135	0.000413	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	0.000135	0.000411	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	0.000135	0.000411	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	0.000132	0.000404	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	0.000132	0.000403	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000131	0.000401	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLG—atherosclerosis	0.000131	0.0004	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	0.000131	0.000399	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	0.000131	0.000399	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	0.00013	0.000397	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000129	0.000393	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SPP1—atherosclerosis	0.000128	0.000391	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—atherosclerosis	0.000128	0.000389	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	0.000127	0.000389	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	0.000127	0.000389	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	0.000127	0.000389	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	0.000124	0.000379	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	0.000122	0.000373	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	0.000122	0.000372	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	0.00012	0.000366	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—atherosclerosis	0.00012	0.000365	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	0.000119	0.000365	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDGFB—atherosclerosis	0.000119	0.000362	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000117	0.000357	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOB—atherosclerosis	0.000116	0.000354	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGT—atherosclerosis	0.000116	0.000353	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	0.000115	0.000352	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000115	0.000351	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOB—atherosclerosis	0.000114	0.000349	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	0.000114	0.000348	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—atherosclerosis	0.000113	0.000346	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—atherosclerosis	0.000113	0.000346	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	0.000113	0.000346	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CAV1—atherosclerosis	0.000112	0.000343	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOA1—atherosclerosis	0.000112	0.000342	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	0.000112	0.000342	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	0.000112	0.000341	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—atherosclerosis	0.000111	0.00034	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	0.000111	0.000339	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LPL—atherosclerosis	0.000111	0.000338	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LPL—atherosclerosis	0.000109	0.000334	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000109	0.000333	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.000108	0.00033	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—atherosclerosis	0.000108	0.00033	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000108	0.000329	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—F2—atherosclerosis	0.000107	0.000326	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—atherosclerosis	0.000107	0.000325	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000105	0.00032	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000104	0.000319	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CD36—atherosclerosis	0.000104	0.000317	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000103	0.000313	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	0.000102	0.000312	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	9.9e-05	0.000302	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	9.86e-05	0.000301	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—atherosclerosis	9.84e-05	0.0003	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	9.8e-05	0.000299	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	9.71e-05	0.000296	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—atherosclerosis	9.68e-05	0.000296	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARA—atherosclerosis	9.66e-05	0.000295	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	9.57e-05	0.000292	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL2—atherosclerosis	9.53e-05	0.000291	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	9.49e-05	0.00029	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGT—atherosclerosis	9.47e-05	0.000289	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	9.42e-05	0.000287	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—atherosclerosis	9.37e-05	0.000286	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AGT—atherosclerosis	9.35e-05	0.000285	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	9.35e-05	0.000285	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—atherosclerosis	9.28e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—atherosclerosis	9.28e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	9.2e-05	0.000281	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	9.18e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—atherosclerosis	9.16e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	9.14e-05	0.000279	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAV1—atherosclerosis	9.08e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOA1—atherosclerosis	9.06e-05	0.000276	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	8.89e-05	0.000271	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	8.89e-05	0.000271	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	8.86e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—F2—atherosclerosis	8.75e-05	0.000267	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	8.66e-05	0.000264	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	8.62e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—atherosclerosis	8.49e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	8.38e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	8.27e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	8.02e-05	0.000245	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	8.01e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—atherosclerosis	7.98e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—atherosclerosis	7.93e-05	0.000242	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—atherosclerosis	7.83e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	7.82e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	7.8e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—atherosclerosis	7.78e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	7.67e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	7.66e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	7.66e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	7.59e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	7.57e-05	0.000231	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	7.53e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	7.31e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	7.28e-05	0.000222	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	7.28e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—F2—atherosclerosis	7.22e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—atherosclerosis	7.18e-05	0.000219	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—atherosclerosis	7.16e-05	0.000219	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	6.95e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	6.91e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—atherosclerosis	6.86e-05	0.000209	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—atherosclerosis	6.81e-05	0.000208	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	6.74e-05	0.000206	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	6.63e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	6.62e-05	0.000202	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	6.61e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—atherosclerosis	6.54e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	6.44e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	6.33e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—atherosclerosis	6.28e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	6.17e-05	0.000188	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	6.12e-05	0.000187	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	6.06e-05	0.000185	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	6.01e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	5.96e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	5.87e-05	0.000179	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	5.79e-05	0.000177	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	5.74e-05	0.000175	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	5.62e-05	0.000171	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	5.58e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	5.52e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	5.43e-05	0.000166	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	5.41e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	5.09e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	5.01e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	4.96e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	4.92e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	4.84e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	4.74e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	4.6e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	4.6e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	4.56e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	4.48e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	4.47e-05	0.000136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—atherosclerosis	4.23e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	4.13e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	4.09e-05	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	3.91e-05	0.000119	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	3.9e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	3.8e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	3.47e-05	0.000106	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.2e-05	9.76e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—atherosclerosis	3.16e-05	9.63e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.86e-05	8.73e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	2.64e-05	8.05e-05	CbGpPWpGaD
